Business Segments · Revenue
Life Sciences: — Revenue
STERIS Life Sciences: — Revenue increased by 0.6% to $145.80M in Q4 2025 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ3 2024
Last reportedQ4 2025
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market share or higher demand for biopharma manufacturing solutions, while a decrease may signal market saturation or reduced capital spending by pharmaceutical clients.
Detailed definition
This metric represents the total revenue generated from the Life Sciences business segment, which provides sterilization...
Peer comparison
Comparable to segment-level revenue reporting in other medical technology or life science tools companies.
Metric ID:
ste_segment_life_sciences_revenuesHistorical Data
4 periods
| Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|
| Value | $127.90M | $136.40M | $145.00M | $145.80M |
| QoQ Change | — | +6.6% | +6.3% | +0.6% |
| YoY Change | — | — | +13.4% | +6.9% |
Range$127.90M – $145.80M
Avg YoY Growth+10.1%
Median YoY Growth+10.1%
Current Streak3+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is STERIS's life sciences: — revenue?
- STERIS (STE) reported life sciences: — revenue of $145.80M in Q4 2025.
- What does life sciences: — revenue mean?
- Total sales generated by the Life Sciences business unit.